OTEZLA 10 mg, film-coated tablet, OTEZLA 20 mg, film-coated tablet 4 tablets
Active ingredients: Apremilast
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet4 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OTEZLA 10 mg, comprimé pelliculé, OTEZLA 20 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé et comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-Aluminium 4 comprimés de 10 mg - plaquette(s) thermoformée(s) PVC-Aluminium 23 comprimés de 20 mg
- Marketing authorisation holder
- AMGEN EUROPE
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Jun 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62999138CIP73030573CIP133400930305737Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| APRÉMILASTcomprimé 10 mg | 10 mg · un comprimé | SA |
| APRÉMILASTcomprimé 20 mg | 20 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.